Kelly Mercier, PhD is a DTRF grant recipient, the DTRF Patient Registry and Natural History Study Principal Investigator, a medical strategy director at Nuvalent, and an adjunct associate professor at Duke University.
Dr. Mercier specializes in precision oncology and patient-centric studies. She is passionate about desmoid tumor research and is thrilled to be able to contribute her scientific knowledge to better understand and treat desmoid tumors.
